Condition
Vaccine Uptake
Total Trials
5
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed4
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07171164Not ApplicableRecruiting
A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults
NCT06698497Not ApplicableCompletedPrimary
Boosting COVID-19 Vaccination Uptake Using Wastewater Surveillance
NCT06290206Not ApplicableCompleted
PREVENT HPV-Related Cancers - BootCamp Translation
NCT05490329Not ApplicableCompleted
Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
NCT05099497Not ApplicableCompleted
Supporting Audit and Feedback to Encourage Vaccine Uptake
Showing all 5 trials